Velocity Bio
PrivateLast Round
Accelerator
Oct 30, 2024
Total Funding Raised
$3M
Company Overview
Velocity Bio operates in Healthcare & Life Sciences and is based in San Carlos, California. Its latest recorded funding round was an Accelerator round in October 2024.
Velocity Bio is a biotechnology company building a biophysical assay platform to deliver a new scale and quality of data to evolve early drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Velocity Bio Comparables
Compare Velocity Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eisbach Bio GmbH | 78% | |
| Octant | 77% | |
| ALLOX | 73% |
For institutional investors. Book with your work email.
Velocity Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Oct 30, 2024 | ||||
| Pre Seed | Nov 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Velocity Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pear VC | Pre Seed |
| Ono Venture Investment, Inc. | Accelerator |
| Mission BioCapital | Pre Seed, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 30, 2024
Led by Mission BioCapital with participation from Ono Venture Investment and Eli Lilly.
- Nov 1, 2023
$3M round led by Pear VC
For institutional investors. Book with your work email.
Velocity Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Velocity Bio's valuation, stock price, and market status.
Is Velocity Bio a public or private company?
Velocity Bio is a private company.
What is the current stock price of Velocity Bio?
Velocity Bio is a private company, so its shares have no public market price. Caplight tracks Velocity Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Velocity Bio worth (valuation)?
Valuation information for Velocity Bio is not publicly available.
Can I buy Velocity Bio stock?
Velocity Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Velocity Bio's last funding round?
Velocity Bio's most recent funding round was Accelerator on October 30, 2024.
Who are the main investors in Velocity Bio?
Key investors in Velocity Bio include Pear VC, Mission BioCapital.
Will Velocity Bio IPO soon?
No public IPO plans have been announced for Velocity Bio.
How can I track Velocity Bio secondary market activity?
Caplight tracks bids, offers, and trades in Velocity Bio's shares on secondary markets.